Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Putting pharmacogenetics into practice

Nature Biotechnology volume 24, pages 403–410 (2006)Cite this article

Genetics is slowly explaining variations in drug response, but applying this knowledge depends on implementation of a host of policies that provide long-term support to the field, from translational research and regulation to professional education.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Corbis

References

  1. Goldstein, D.B., Tate, S.K. & Sisodiya, S.M. Pharmacogenetics goes genomic. Nat. Rev. Genet. 4, 937–947 (2003).

    Article  CAS  Google Scholar 

  2. Editorial. Pharmacogenetics to come. Nature 425, 749 (2003).

  3. Schmedders, M., van Aken, J., Feuestein, G. & Kollek, R. Individualized pharmacogenetic therapy: a critical analysis. Community Genet. 6, 114–119 (2003).

    PubMed  Google Scholar 

  4. Tucker, G. Pharmacogenetics expectations and reality. BMJ 329, 4–6 (2004).

    Article  Google Scholar 

  5. Weinshilboum, R. & Wong, L. Pharmacogenomics: from bench to bedside. Nat. Rev. Drug Discov. 3, 739–748 (2004).

    Article  CAS  Google Scholar 

  6. Motulsky, A. Drug reactions enzymes, and biochemical genetics. JAMA, 165, 835–837 (1957).

    Article  CAS  Google Scholar 

  7. Snedden, R. Pharmacogenetics Workshop Background paper. The Wellcome Trust, London, UK. http://www.wellcome.ac.uk/assets/wtd003274.pdf (1999).

    Google Scholar 

  8. Lindpaintner, K. The impact of pharmacogenetics and pharmacogenomics on drug discovery. Nat. Rev. Drug Discov. 1, 463–469 (2002).

    Article  CAS  Google Scholar 

  9. FDA workshop on pharmacogenetics/pharmacogenomics in drug development and regulatory decision making. May 16–17, 2002, University of Maryland, Rockville, MD.

  10. Martin, P.A., Lewis, G., Smart, A. & Webster, A. False Positive? Prospects for the Clinical and Commercial Development of Pharmacogenetics (University of Nottingham/University of York, Nottingham, UK, (2006).

    Google Scholar 

  11. Webster, A., Martin, P., Lewis, G. & Smart, A. Integrating pharmacogenetics into society: in search of a model. Nat. Rev. Genet. 5, 663–669 (2004).

    Article  CAS  Google Scholar 

  12. Sargent, D., Conley, B., Allegra, C. & Collette, L. 'Clinical trial design for predictive marker validation in cancer treatment trails'. J. Clin. Oncol. 23, 2020–2027 (2005).

    Article  Google Scholar 

  13. College of American Pathologists. Cell Markets and Cytogenetic Committees Clinical Laboratory Assays for HER-2/neu amplification and overexpression: quality assurance, standardization and proficiency testing. Arch. Pathol. Lab. Med. 126, 803–808 (2002).

  14. Ford, L., Cooper, S., Lewis, M. & Berg, J. Reference intervals for thiopurine S methytransferase activity in red blood cells using 6 thioguanine as substrate and rapid non-extraction liquid chromatography. Ann. Clin. Biochem. 41, 303–308 (2004).

    Article  CAS  Google Scholar 

  15. Winter, J. et al. Cost effectiveness of thiopurine methyl transferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Aliment. Pharmacol. Ther. 20, 593–599 (2004).

    Article  CAS  Google Scholar 

  16. Woelderink, A., Ibarreta, D., Hopkins, M.M. & Rodriguez-Cerezo, E. The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies. Pharmacogenomics J. 6, 3–7 (2006).

    Article  CAS  Google Scholar 

  17. European Commission Independent Expert Group. 25 recommendations on the ethical, legal and social aspects of genetic testing: research, development and clinical applications. Luxembourg: Office for Official Publications of the European Communities (2004). http://europa.eu.int/comm/research/conferences/2004/ genetic/pdf/recommendations_en.pdf

  18. Nuffield Council on Bioethics. Pharmacogenetics: Ethical Issues (Nuffield Council, London, 2003).

  19. Hedgecoe, A.M. The Politics of Personalised Medicine: Pharmacogenetics in the Clinic: Cambridge Studies in Society and the Life (Sciences Cambridge University Press, Cambridge UK, 2005).

    Google Scholar 

Download references

Acknowledgements

This study was funded by the European Commission through the European Science and Technology Observatory network (ESTO). Parts of the analysis have relied heavily on prior and continuing work funded in the UK by the Wellcome Trust (grants GR061491MA, GR063308,) the Economic and Social Research Council and the Medical Research Council (grants RES-151-25-0049, PTA-037-27-0029). Further details on much of this body of research are available from http://www.nottingham.ac.uk/igbis/pgx, http://www.york.ac.uk/res/pgx and http://www.wellcome.ac.uk/. The authors are grateful to Ignacio Garcia-Ribas, David Gurwitz, Detlef Niese, Marisa Papaluca and Sandy Thomas for feedback on drafts of project reports as well as to our anonymous interviewees and survey respondents who all gave generously of their time. The views expressed here are those of the authors and do not necessarily reflect the views of the European Commission.

Author information

Authors and Affiliations

  1. SPRU: Science and Technology Policy Research, The Freeman Centre, University of Sussex, Brighton, BN1 9QE, UK

    Michael M Hopkins & Paul Nightingale

  2. European Commission Joint Research Center, Institute for Prospective Technological Studies, Edificio Expo, Inca Garcilaso, Seville, E-41092, Spain

    Dolores Ibarreta

  3. Fraunhofer Institute Systems and Innovation Research, 48 Breslauer Str., Karlsruhe, 76139, Germany

    Sibylle Gaisser, Marieke Dreiling & K Juliane Hartig

  4. TNO: Netherlands Organization for Applied Scientific Research, Innovation Policy Group, 97 Schoenmakerstraat, PO Box 6030, Delft, 2600 JA, The Netherlands

    Christien M Enzing, Symone Detmar, M Elske van den Akker-van Marle & Wieneke Vullings

  5. The CIRCA Group Europe Limite, 26 Upper Pembroke St., Dublin, 2, Ireland

    Jim Ryan & Tony Forde

  6. Institute for the Study of Genetics, Biorisks and Society, University of Nottingham, Nottingham, NG7 2RD, UK

    Paul A Martin

  7. Science and Technology Studies Unit, University of York, York, YO10 5DD, UK

    Graham Lewis

  8. Department of Sociology, University of Sussex, BN1 9SN, UK

    Adam M Hedgecoe

Authors
  1. Michael M Hopkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dolores Ibarreta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sibylle Gaisser
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christien M Enzing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jim Ryan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paul A Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Graham Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Symone Detmar
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Elske van den Akker-van Marle
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Adam M Hedgecoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Paul Nightingale
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Marieke Dreiling
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. K Juliane Hartig
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Wieneke Vullings
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Tony Forde
    View author publications

    You can also search for this author in PubMed Google Scholar

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hopkins, M., Ibarreta, D., Gaisser, S. et al. Putting pharmacogenetics into practice. Nat Biotechnol 24, 403–410 (2006). https://doi.org/10.1038/nbt0406-403

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0406-403

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing